Oxehealth was featured in the top 19 UK healthcare companies by Beauhurst, who specialize in researching and analyzing the UK’s fastest growing companies.
Oxehealth is delighted to announce that, with our partners; South London and Maudsley FT, Oxford Health, Coventry and Warwickshire Partnership Trust, we have been shortlisted for FOUR separate HSJ Partnership Awards!
We at Oxehealth are delighted to announce that we've been selected as one of the “First 100 Digital Health Companies” by Healthcare UK. The list was announced by Healthcare UK this morning.
The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.
Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.